Pricing Log in Create free account
Friday 6 November 2026 Export BKYI’s income statement to Excel — free account

BIO-key International Inc.

BKYI Industrials Security & Protection Services

BIO-key International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.9 million, down 14.3% from fiscal 2024.

Revenue
+13.2%
EPS
+72.0%
Free cash flow
+4.04%
Total debt
−90.1%

Quarter to June 2026, against a year earlier

2.39 0.03 +1.27%
Market cap
$4.8M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
3/9
Altman Z
−24.13
Beneish M
−3.33
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Size
Market Cap 4.82
Revenue ttm 6.70
Net income ttm (6.04)
Free cash flow ttm (4.16)
Net debt Q (1.37)
Valuation
P/E 0.00
Forward P/E 0.00
Price / sales 0.37
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.57
Financial health
Current ratio Q 1.26
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q (19.61)
Growth
Revenue growth Q +13.15% (above 0%: growing)
Operating income growth Q +51.16% (above 0%: growing)
EPS, this year +76.52% (at or above 15%: strong)
EPS, next year A +113.58% (at or above 15%: strong)
Revenue, next year A +51.58% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.3×, against a ten-year median of 1.8×; over the ten years it ranged from −0.2× in 2024 to 11.2× in 2020.
P/S against its own 10 years 11.07%
10-year low 10-year high
P/B against its own 10 years 5.47%
10-year low 10-year high
EV/Sales against its own 10 years 12.47%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 1 0 3 1
Receivables 1 1 1 2
Inventory 0 0 0 0
Other — — — —
3 2 5 4
2023 2024 2025 Q'26
Payables 1 1 1 0
ST’ Debt 0 0 0 0
Other — — — —
3 5 3 3

Compound Annual Growth %

10y 5y 3y
Sales 1.22% 15.92% (5.43%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value (11.91%) (24.15%) (1.24%)

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate −0.82 Actual −0.56

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY16 −172.73 −345.46 Miss by 172.73
Q2 FY26 −0.82 −0.56 Beat by 0.26
Q3 FY26 −0.35 — Reports 13 November 2026

EPS $

Mar Jun Sep Dec Year
’26 (0.15) (0.56) — — —
’25 (1.60) (2.00) (1.50) (4.52) (10.77)
’24 (3.20) (10.00) (3.90) (4.51) (21.00)
’23 (35.11) (47.11) (32.20) (37.68) (152.10)
’22 (21.58) (37.77) (52.16) (158.65) (272.65)
’21 (16.19) (26.98) (23.38) (46.76) (116.91)
’20 (330.93) (115.11) (86.33) (32.37) (374.10)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 2 2 — — —
’25 2 2 2 1 6
’24 2 1 2 1 7
’23 2 2 2 2 8
’22 2 2 1 2 7
’21 2 1 1 1 5
’20 1 0 1 1 3
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 0 (1) — — —
’25 (1) (1) (1) (2) (5)
’24 0 (1) (1) (1) (3)
’23 (2) 0 0 (2) (4)
’22 (1) (1) (2) (2) (6)
’21 (3) (2) (2) (2) (9)
’20 (1) (1) (2) (1) (5)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 0 (1) — — —
’25 (1) (1) (1) (2) (5)
’24 0 (1) (1) (1) (3)
’23 (2) 0 0 (2) (4)
’22 (1) (1) (2) (2) (6)
’21 (3) (2) (2) (2) (9)
’20 (1) (3) (2) (1) (5)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 3 6 4 2 3 5 7 8 7 6 7 +8.0% 9 12 — +42.2%
Gross margin, % 75.48 48.56 (2.96) (8.54) 71.98 67.29 65.25 18.46 81.39 76.87 81.32 +1.4 pt
EBT (4) (4) (7) (15) (10) (5) (12) (9) (4) (7) (6) +6.1%
EBT margin, % (140.79) (67.83) (169.83) (643.38) (341.02) (99.05) (169.94) (111.62) (62.39) (120.27) (89.86) +20.5 pt
Net income (4) (4) (7) (15) (10) (5) (12) (9) (4) (7) (6) +6.1%
Per share, $
Per share, $ Revenue 763.03 1,370.22 499.32 229.04 108.69 118.12 160.65 138.48 33.64 8.93 6.46 (39.0%)
Earnings (1,280.58) (1,093.52) (1,050.36) (1,482.01) (374.10) (116.91) (272.65) (152.10) (21.00) (10.77) (6.73) (41.2%)
Cash flow (1,140.21) (535.98) (199.20) (186.90) (189.66) (207.35) (142.54) (67.74) (14.15) (7.02) (4.01) (43.2%)
Capex (13.59) (49.30) (10.19) (3.08) (1.36) (0.97) (1.88) (0.02) (0.06) (0.02) 0.00 (52.1%)
Free cash flow (1,153.79) (585.28) (209.38) (189.98) (191.02) (208.32) (144.42) (67.76) (14.21) (7.04) (4.01) (43.3%)
Book value 3,962.28 2,989.85 1,292.12 (230.83) 779.12 360.64 121.32 18.99 18.31 7.68 4.18 (50.0%)
Shares, m 0 0 0 0 0 0 0 0 0 1 1 +77.0%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
P/S 4.77 1.98 2.16 3.14 5.83 3.37 0.72 0.20 0.51 0.60 0.37 2.3
P/B 0.92 0.91 0.84 0.00 0.81 1.10 0.95 1.45 0.93 0.70 0.57 0.9
EV/Sales 4.42 1.93 2.08 4.12 (0.08) 1.90 0.40 0.17 0.47 0.33 0.32 1.6
EV/FCF (2.92) (4.62) (5.06) (4.97) 0.03 (0.88) (0.34) (0.23) (0.66) (0.29) (0.34) (2.0)
Cash, $m
Cash, $m Operating cash flow (4) (2) (2) (2) (5) (9) (6) (4) (3) (5) (4) +0.5%
Capex 0 0 0 0 0 0 0 0 0 0 0 (15.2%)
Free cash flow (4) (3) (2) (2) (5) (9) (6) (4) (3) (5) (4) +0.4%
Balance, $m
Balance, $m Working capital 3 5 3 (3) 17 12 4 (1) (3) 1 1 (8.1%)
Net debt (1) 0 0 2 (17) (7) (2) 0 0 (3) (1) +10.7%
Shareholders’ equity 15 14 10 (2) 20 16 5 1 4 5 4 (11.6%)
Returns, %
Returns, % ROA (26.48) (30.24) (61.19) (205.63) (78.24) (25.15) (81.82) (107.45) (65.50) (84.61) (67.07) (58.1) pt
ROIC (18.25) (19.85) (42.33) 0.00 (91.36) (38.01) (199.24) (627.08) (71.38) (173.28) (121.93) (155.0) pt
ROE (29.71) (34.54) (70.16) (356.65) (108.44) (28.18) (113.88) (267.77) (177.88) (161.24) (107.91) (131.5) pt
People
People Employees 21 19 18 15 34 51 51 43 42 42 — +8.0%
Revenue/emp, $m 0.14 0.33 0.22 0.15 0.08 0.10 0.14 0.18 0.16 0.14 — 0.0%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026

BIO-key International Inc. vs peers in Security & Protection Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CIGL Concorde International Group Ltd. $44.5M — — — — −980.96% (below 0%: shrinking) — — Compare
SNT Senstar Technologies Ltd. $30.3M 95.6× — +8.21% (above 0%: growing) −70.00% (below 0%: shrinking) +251.01% (above 0%: growing) 64.20% 3.29% Compare
BAER Bridger Aerospace Group Holdings, Inc. $12.0M — (loss-making) — (loss-making) −0.84% (below 0%: shrinking) n/m −9,846.91% (below 0%: shrinking) 37.13% 19.72% Compare
KSCP Knightscope, Inc. $9.8M — (loss-making) — (loss-making) +228.26% (above 0%: growing) n/m −107.72% (below 0%: shrinking) 7.36% (145.09%) Compare
DETX Liberty Defense Holdings Ltd. $7.3M — — — n/m — 2.29% (279.56%) Compare
GFAI Guardforce AI Co., Limited $5.5M — (loss-making) — (loss-making) +0.05% (above 0%: growing) n/m +51.02% (above 0%: growing) 6.64% 0.00% Compare
BKYI BIO-key International Inc. $4.8M — (loss-making) — (loss-making) +13.15% (above 0%: growing) n/m +4.04% (above 0%: growing) 87.19% (27.57%)
SUGP SU Group Holdings Limited $3.9M — — — — — — — Compare
IVDA Iveda Solutions, Inc. $2.4M — (loss-making) 0.8× −47.52% (below 0%: shrinking) n/m −7.79% (below 0%: shrinking) 54.70% (88.56%) Compare
Median of peers $8.6M — — +0.05% — −57.75% 22.25% (44.28%)

All 22 Security & Protection Services stocks →

Pay and ownership Proxy statement filed 24 July 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 346.82k 309.43k 5.08
2024 309.49k 277.10k 16.10
2023 291.53k 261.33k 28.25

Ownership

Directors and executive officers, together 4.00%
Fiber Food Systems, Inc. 5.50%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

BIO-key International Inc. (BKYI) Latest News

28 Oct

Impact 4 · · InvestorsHub
Impact 4 · · GlobeNewswire

22 Oct

Impact 4 · · GlobeNewswire

13 Oct

Impact 4 · · GlobeNewswire
Impact 4 · · GlobeNewswire
Impact 3 · · InvestorsHub
Impact 3 · · Benzinga

29 Sep

Impact 4 · · GlobeNewswire
Impact 3 · · InvestorsHub

23 Sep

Impact 4 ·

21 Aug

Impact 3 · · The Motley Fool transcript

14 Aug

Impact 3 ·
Impact 3 · · Moby transcript

13 Aug

Impact 3 ·

10 Aug

Impact 4 ·

6 Aug

Impact 3 ·

28 Jul

Impact 4 ·

19 May

Impact 3 · · Moby transcript

18 May

Impact 4 · · GuruFocus.com
Impact 4 · · GlobeNewswire

12 May

Impact 4 · · GlobeNewswire

22 Apr

Impact 3 · · GlobeNewswire

16 Apr

Impact 4 · · GlobeNewswire

1 Apr

Impact 4 · · Moby

31 Mar

Impact 4 · · GuruFocus.com
Impact 4 · · GlobeNewswire

18 Mar

Impact 4 · · Simply Wall St.

12 Mar

Impact 4 · · GlobeNewswire

5 Mar

Impact 4 · · GlobeNewswire

3 Mar

Impact 4 ·
stockrow.com/BKYI · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com